Inogen Inc (INGN) Dividend Safety Gauge & 10-Year DRIP Compounder

Per the Roarable RQD rating, INGN scores 36 out of 100 with a letter grade of D-, labeled "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are: Fundamental Cash Engine at 1/20 (ROIC of -27% and FCF yield of -7.13%); Whale 13F Flow at 14/20 (institutional accumulation and options positioning); Insider Conviction at 7/20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit at 7/20 (Beta of 1.0 with sector sensitivity); and Forensic Balance Sheet at 7/20 (Altman Z of 1.46, Piotroski F of 4/9, Debt/Equity of 0.5).

The weakest pillar is the cash engine, which the rating scores at 1 of 20. For a prospective investor, this means the rating system sees the business as currently consuming capital rather than generating it. The institutional flow pillar is the strongest at 14 of 20, indicating the rating registers positive positioning from larger holders, but this offsets only part of the weakness in fundamentals. Forensic metrics sit in the middle range, which the rating interprets as a balance sheet that is neither a clear distress signal nor a strength. Any upside case would need to rest on a turnaround in cash generation, since that is the pillar carrying the most drag. Valuation metrics (trailing P/E of 8.5 and forward P/E of 7.9) look low in isolation, but per the market data they sit alongside negative ROIC and negative free cash flow yield, which is a tradeoff worth weighing: a low multiple can reflect skepticism about earnings quality rather than a bargain.

Inogen Inc (INGN) is a NASDAQ-listed issuer classified under the Health Care sector and the Industrial Specialties industry, per the profile section. The source data does not describe its specific products, customers, or revenue model. Per the financials, the company reported revenue of $295.3M for FY 2025, indicating an operating business of meaningful scale relative to its market capitalization. Beyond sector, industry, exchange, and these reported financial figures, the source data does not establish how the company makes money.

Per the SEC financials, revenue rose from $251.6M in FY 2023 to $295.3M in FY 2025, while operating income was negative in every reported year. Net income was positive despite operating losses, a divergence the source data does not explain. Per the market data, gross margin is 52.2%, operating margin is -10.2%, net margin is 7.7%, and ROIC is -27%. Per the Roarable RQD rating, the Altman Z-Score is 1.46, the Piotroski F-Score is 4/9, and Debt/Equity is 0.5, placing the balance sheet in the middle range of the forensic pillar. Reported cash declined from $113.8M to $103.7M between FY 2024 and FY 2025.

Per the recent news and catalysts section, five items are listed, all tagged to INGN: Stocktwits market coverage (YELLOW), a Seeking Alpha piece titled "Inogen: Cheap Enough To Take A Chance On" (YELLOW), a Yahoo! Finance seasonal returns chart (YELLOW), a Benzinga transcript of the Q2 2026 earnings call (YELLOW), a TradingView item noting a Q3'26 revenue estimate of 92.23M USD (YELLOW), and a Simply Wall St article titled "What Inogen Investors Missed Before The Fall" (RED, labeled RISK WATCH). The only item flagged as a risk watch is the Simply Wall St piece. The source data provides headlines and summaries only; the article contents are not available. Per the butterfly supply-chain graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals.

Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals. The source data therefore contains no upstream or downstream dependency mapping, no sector correlation data, and no identified 2nd-order bottlenecks. A prospective investor should recognize that this section cannot confirm supply-chain exposure in either direction.

• What are the company's specific products, customers, and revenue drivers, given that the source data records only sector and industry classification?
• Why did net income remain positive in FY 2023 through FY 2025 despite negative operating income in each year, and what drove the gap?
• What is the debt balance, since the financials list debt as N/A, and how does it reconcile with the reported Debt/Equity of 0.5?
• What specific content in the RISK WATCH item from Simply Wall St drove its risk classification?
• What explains the divergence between institutional accumulation (14/20 whale flow pillar) and the weak cash engine (1/20), and what is the insider Form 4 activity behind the 7/20 insider pillar?